Cabozantinib in Patients with Advanced Merkel Cell Carcinoma

BACKGROUND. This study sought to determine the efficacy and safety profile of cabozantinib in patients with advanced Merkel cell carcinoma (MCC). EXPERIMENTAL DESIGN. This prospective, phase II, single‐institution trial enrolled patients with platinum‐failure, recurrent/metastatic MCC to receive cab...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Rabinowits, Guilherme, Lezcano, Cecilia, Catalano, Paul J., McHugh, Patricia, Becker, Hailey, Reilly, Megan M., Huang, Julian, Tyagi, Ayushi, Thakuria, Manisha, Bresler, Scott C., Sholl, Lynette M., Shapiro, Geoffrey I., Haddad, Robert, DeCaprio, James A.
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2018
Materias:
Melanoma and Cutaneous Malignancies
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058327/
https://ncbi.nlm.nih.gov/pubmed/29445030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0552
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares